There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Esperion (ESPR – Research Report), OrthoPediatrics...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aileron Therapeutics (ALRN – Research Report) and...
In a report released on August 5, Rick Wise from Stifel Nicolaus maintained a Buy rating on OrthoPediatrics (KIDS - Research Report), with a price...
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on OrthoPediatrics (KIDS – Research Report), with a price target of...
After BTIG and Stifel Nicolaus gave OrthoPediatrics (NASDAQ: KIDS) a Buy rating last month, the company received another Buy, this time from...
BTIG analyst Ryan Zimmerman maintained a Buy rating on OrthoPediatrics (KIDS – Research Report) today and set a price target of $65.00. The...
JMP Securities analyst David Turkaly reiterated a Buy rating on OrthoPediatrics (KIDS – Research Report) today and set a price target of $77.00...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Clovis Oncology (CLVS – Research Report) and...
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Altimmune (ALT – Research Report) and...
In a report issued on May 6, Rick Wise from Stifel Nicolaus maintained a Buy rating on OrthoPediatrics (KIDS – Research Report), with a price...
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BioCryst (BCRX – Research Report), Concert Pharma...
Needham analyst Michael Matson reiterated a Buy rating on OrthoPediatrics (KIDS – Research Report) today and set a price target of $59.00. The...
In a report released today, David Turkaly from JMP Securities reiterated a Buy rating on OrthoPediatrics (KIDS – Research Report), with a price...
In a report released today, Michael Matson from Needham maintained a Buy rating on OrthoPediatrics (KIDS – Research Report), with a price target...
After Stifel Nicolaus and BTIG gave OrthoPediatrics (NASDAQ: KIDS) a Buy rating last month, the company received another Buy, this time from JMP...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.